Free Trial

Pharming Group (PHAR) Earnings Date, Estimates & Call Transcripts

$8.76
+0.38 (+4.53%)
(As of 07/12/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1
Before Market Opens
Confirmed
Actual EPS
(May. 8)
-$0.19 Missed By -$0.20
Consensus EPS
(May. 8)
$0.01
Skip Charts & View Estimated and Actual Earnings Data

PHAR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PHAR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pharming Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.01$0.01$0.01 
Q2 20241$0.02$0.02$0.02 
Q3 20241$0.01$0.01$0.01 
Q4 20241$0.01$0.01$0.01 
FY 20244$0.05$0.05 $0.05

PHAR Earnings Date and Information

Pharming Group last posted its quarterly earnings results on May 8th, 2024. The reported ($0.19) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.20. The company had revenue of $55.59 million for the quarter, compared to analyst estimates of $68.43 million. Pharming Group has generated ($0.16) earnings per share over the last year (($0.16) diluted earnings per share). Earnings for Pharming Group are expected to grow in the coming year, from ($0.03) to $0.20 per share. Pharming Group has confirmed that its next quarterly earnings report will be published on Thursday, August 1st, 2024.

Pharming Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Confirmed)
------- 
5/8/2024Q1 2024$0.01($0.19)($0.20)($0.19)$68.43 million$55.59 million
3/14/2024Q4 2023$0.05($0.03)($0.08)($0.02)$71.83 million$81.20 million
10/26/2023Q3 2023$0.13$0.05($0.08)$0.05$61.67 million$66.66 million
8/3/2023Q2 2023($0.02)$0.02+$0.04$0.02$51.80 million$54.90 million
5/11/2023Q1 2023($0.01)($0.17)($0.16)($0.17)$48.15 million$42.54 million
3/16/2023Q4 2022$0.01($0.19)($0.20)($0.17)$57.94 million$54.62 million
10/27/2022Q3 2022$0.02$0.13+$0.11$0.13$53.52 million$54.24 million
8/4/2022Q2 2022$0.01$0.04+$0.03($0.14)$51.99 million$50.15 million
5/12/2022Q1 2022-$0.05+$0.05$0.05$48.00 million$46.62 million
3/17/2022Q4 2021$0.01$0.01-$0.01$57.59 million$52.77 million
10/28/2021Q3 2021-($0.04)($0.04)($0.04)-$28.70 million
8/5/2021Q2 2021$0.01$0.06+$0.05$0.06$64.13 million$49.60 million
5/13/2021Q1 2021$0.01$0.13+$0.12$0.13$60.50 million$43.45 million
3/4/2021Q4 2020$0.01$0.13+$0.12$0.13$61.69 million$60.80 million

Pharming Group Earnings - Frequently Asked Questions

When is Pharming Group's earnings date?

Pharming Group has confirmed that its next quarterly earnings data will be published on Thursday, August 1st, 2024. Learn more on PHAR's earnings history.

What guidance has Pharming Group issued on next quarter's earnings?

Pharming Group issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company issued revenue guidance of $280.0 million-$295.0 million.

Did Pharming Group beat their earnings estimates last quarter?

In the previous quarter, Pharming Group (NASDAQ:PHAR) missed the analysts' consensus estimate of $0.01 by $0.20 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. PHAR's actual earnings.

How much revenue does Pharming Group generate each year?

Pharming Group (NASDAQ:PHAR) has a recorded annual revenue of $245.32 million.

How much profit does Pharming Group generate each year?

Pharming Group (NASDAQ:PHAR) has a recorded net income of -$10.55 million. PHAR has generated -$0.16 earnings per share over the last four quarters.

What is Pharming Group's EPS forecast for next year?

Pharming Group's earnings are expected to grow from ($0.03) per share to $0.20 per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:PHAR) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners